MARKET

MIRA

MIRA

Mira Pharma
NASDAQ
1.189
-0.061
-4.88%
Opening 12:32 03/14 EDT
OPEN
1.250
PREV CLOSE
1.250
HIGH
1.250
LOW
1.110
VOLUME
565.02K
TURNOVER
--
52 WEEK HIGH
5.01
52 WEEK LOW
0.5100
MARKET CAP
19.69M
P/E (TTM)
-1.6317
1D
5D
1M
3M
1Y
5Y
1D
Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Gives Stock $17.75 Price Valuation
Benzinga · 1d ago
MIRA PHARMACEUTICALS INC - ADVANCING KETAMIR-2 TOPICAL TREATMENT DEVELOPMENT FOR FUTURE CLINICAL TRIALS
Reuters · 1d ago
EXCLUSIVE: MIRA Pharmaceuticals Expands Pipeline, Enhances Value Proposition With Development Of Topical Formulation For Lead Pain Treatment Candidate
Benzinga · 1d ago
'Nevada Senators Take Up Resolution Calling On Congress To Reschedule Psychedelics And Streamline Research' - Marijuana Moment
Benzinga · 2d ago
Weekly Report: what happened at MIRA last week (0303-0307)?
Weekly Report · 4d ago
Psychedelic: MindMed reports Q4 earnings results
TipRanks · 03/06 16:31
Mira Pharmaceuticals announces approval, initiation of Phase 1 Ketamir-2 trial
TipRanks · 03/04 13:31
MIRA PHARMACEUTICALS ANNOUNCES APPROVAL AND INITIATION OF PHASE 1 CLINICAL TRIAL FOR KETAMIR-2 IN NEUROPATHIC PAIN
Reuters · 03/04 13:08
More
About MIRA
More
MIRA Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical development company. The Company has two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. It holds exclusive license rights in the United States, Canada and Mexico for Ketamir-2, a patent pending oral ketamine analog under pre-clinical investigation to potentially deliver ultra-rapid antidepressant effects, providing hope for individuals battling treatment-resistant depression (TRD), major depressive disorder with suicidal ideation (MDSI) and potentially post-traumatic stress disorder (PTSD). Its oral pharmaceutical marijuana molecule, MIRA-55, is being studied for its potential to alleviate neuropathic pain, as well as anxiety and cognitive decline, symptoms commonly associated with early-stage dementia.
Recently
Symbol
Price
%Change

Webull offers Mira Pharmaceuticals Inc stock information, including NASDAQ: MIRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MIRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MIRA stock methods without spending real money on the virtual paper trading platform.